Quantum Cyber N.V. current report, Q1 FY2025

Business Context and Reporting Period

This Form 6-K filing by Mainz Biomed N.V. (noted as Quantum Cyber N.V. in metadata) is dated January 14, 2025. The report addresses compliance with Nasdaq Listing Rule 5550(b)(1) regarding the minimum $2.5 million stockholders' equity requirement for continued listing on the Nasdaq Capital Market.

Key Financial Metrics

  • Stockholders' Equity (June 30, 2024): Approximately $(4.1) million (deficit).
  • Stockholders' Equity (Current): Above the $2.5 million requirement following recent capital events.
  • Recent Capital Raises:
    • Convertible note issuance: $1.34 million net proceeds.
    • Share issuance via convertible note conversion: ~$7.4 million principal and interest.
    • Pre-Paid Advance Agreement proceeds: ~$6.1 million (1,281,836 shares).
    • Registered direct offering (December 2024): ~$7.1 million net proceeds.
  • Revenue, Profit, Cash Flow, Margins, Debt: The filing text does not provide specific values for these metrics beyond the equity and capital raise figures.

Material Changes

The company previously failed to meet the minimum stockholders' equity requirement based on unaudited financial statements for the six-month period ended June 30, 2024, resulting in a Nasdaq staff determination letter dated November 27, 2024. Since that date, the company executed multiple financing activities totaling approximately $21.94 million in gross value (including conversions and proceeds), which restored stockholders' equity to above the $2.5 million threshold.

Outlook, Risks, and Management Commentary

Management states that the company is currently in compliance with the Stockholders' Equity Requirement. However, Nasdaq will continue to monitor ongoing compliance. The filing notes a material risk: if the company fails to evidence compliance in its next periodic report, it may be subject to delisting.

Investor Verification Checklist

  • Verify the exact current stockholders' equity balance in the most recent audited or unaudited financial statements to confirm the $2.5 million threshold is met.
  • Confirm the status of the Nasdaq determination letter and any subsequent correspondence regarding the delisting risk.
  • Review the terms of the convertible notes and Pre-Paid Advance Agreement for potential future dilution or debt obligations.
  • Check the company's cash runway given the reliance on recent equity and debt financing to address the equity deficit.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.